Spruce Capital Partners LLC and Xeraya Capital have raised $150 million in the first close of their MLS Capital Fund II, the successor fund to the $162 million Malaysian Life Sciences Capital Fund.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in